World’s First Lung Cancer Vaccine Trial Underway in Seven Countries

The world’s first clinical trial for a lung cancer vaccine is currently underway in seven countries, marking a significant milestone in cancer treatment. The trial, which includes the United States, United Kingdom, Germany, Hungary, Poland, Spain, and Turkey, is testing an mRNA vaccine developed by BioNTech, the same company behind one of the leading COVID-19 vaccines.

This Phase One clinical trial focuses on treating non-small cell lung cancer (NSCLC), the most common form of lung cancer, which accounts for approximately 85% of all lung cancer cases. The. . .